Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
35,942,904
-
Shares change
-
-5,067,951
-
Total reported value, excl. options
-
$152,770,000
-
Value change
-
-$14,006,145
-
Put/Call ratio
-
27.9%
-
Number of buys
-
51
-
Number of sells
-
-21
-
Price
-
$4.25
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q1 2016
88 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q1 2016.
TRANSENTERIX INC - COM NEW (TRXC) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,942,904 shares
.
Largest 10 shareholders include Aisling Capital LLC (8,335,819 shares), SV Life Sciences Advisers, LLC (7,546,692 shares), StepStone Group LP (3,480,512 shares), JPMORGAN CHASE & CO (3,230,205 shares), MASTERS CAPITAL MANAGEMENT LLC (3,000,000 shares), VANGUARD GROUP INC (1,807,919 shares), BlackRock Fund Advisors (1,193,469 shares), BlackRock Institutional Trust Company, N.A. (792,603 shares), STATE STREET CORP (684,234 shares), and GOLDMAN SACHS GROUP INC (467,207 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.